- Home
- Paediatric Neurology
- Efficacy and Safety of Tolebrutinib in Primary Progressive Multiple Sclerosis: Insights from the PERSEUS Phase 3 Trial

2w3 min read
Medical Article
Introduction: Primary Progressive Multiple Sclerosis (PPMS) is characterised by a gradual accumulation of disability from disease onset, without relapses (1). This form of multiple sclerosis presents significant therapeutic challenges due to the absence of approved disease-modifying therapies (DMTs) (1). The pathophysiology of PPMS involves central

Efficacy and Safety of Tolebrutinib in Primary Progressive Multiple Sclerosis: Insights from the PERSEUS Phase 3 Trial
909 Reached3 Comments
Similar Content

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes

Spinal Anesthesia in Elderly Patient
4200 Reached10 Comments7 Likes

Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes

Neurotrophic Deep Corneal Ulcer in Old Male
1139 Reached5 Comments4 Likes